Regenerative Medical Technology Group Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $686.9K
- Price
- $0.05
- % Change (Daily % change from the live per-ticker quote feed.)
- -4.76%
- Volume
- 52.4K
About
Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions. The company was formerly known as Meso Numismatics, Inc. and changed its name to Regenerative Medical Technology Group Inc. in May 2024. Regenerative Medical Technology Group Inc. was incorporated in 1999 and is based in Boca Raton, Florida.
Quick stats
Shares outstanding13.7M
Computed float12.7M
Float / shares92.4%
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001760026
AI Summary
AI-generated1/19
minorbullishproduct launch
RMTG Broadens Longevity Footprint With New ISSCA Certification Across Adjunctive Therapies
RMTG announced a new Longevity and Adjunctive Therapies Certification from its ISSCA division covering multi-modality longevity medicine, including plasma exchange, peptide medicine, and hyperbaric approaches.
The program is designed to complement clinical capabilities being developed at the Company's Cellular Hope Institute clinic in Cancún, though the release clarifies not every covered technology is currently offered or authorized there.
The launch expands ISSCA's educational footprint, which has trained more than 12,000 physicians across 45+ countries, but the release notes these are company-issued credentials, not governmental or board-specialty accreditation.
Red flags
- Company-issued certification, explicitly not a governmental or board-specialty accreditation
- Release notes not all covered technologies are authorized or available at Cellular Hope Institute
- Issuer flags going-concern doubt, liquidity needs, substantial debt, and history of operating losses in forward-looking statement boilerplate